China’s Biotech Is Quietly Eating Big Pharma’s Lunch

Chinese biotech is no longer playing catch-up it’s becoming the main event. In 2024, more than 1,250 innovative drugs entered development in China, nearly overtaking the US and leaving the EU behind. This isn’t just a numbers game. Chinese firms like Akeso (AKESF) are now developing therapies that are outperforming global blockbusters like Merck’s Keytruda…

Read More
China, EU hold high-level environment, climate dialogue

China, EU hold high-level environment, climate dialogue

Chinese Vice Premier Ding Xuexiang held the sixth China-EU High-Level Environment and Climate Dialogue jointly with Teresa Ribera, Executive Vice President of the European Commission, on Monday in Beijing, News.az reports citing Xinhua. Ding, also a member of the Standing Committee of the Political Bureau of the Communist Party of China Central Committee, urged both…

Read More